The startup develops a diagnostic device that utilizes advanced imaging techniques to assess coronary artery lesions, providing detailed insights into the nature of occlusions. This technology enables precise diagnosis, leading to symptom relief, improved left ventricular function, and enhanced long-term survival for patients.
Funding
$220K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Coronary artery disease diagnosis relies on invasive procedures or imaging techniques with limited resolution, hindering accurate assessment of lesion morphology and severity. This can lead to imprecise treatment planning and suboptimal outcomes for patients with suspected or confirmed coronary artery disease.
Solution
The company develops an advanced diagnostic imaging system for detailed assessment of coronary artery lesions. The system utilizes high-resolution imaging modalities to visualize the structure and composition of arterial plaques, providing clinicians with comprehensive information about the nature and extent of coronary artery occlusions. This enables more precise diagnosis, risk stratification, and treatment planning, potentially leading to improved patient outcomes and reduced need for invasive procedures.
Target Audience
The primary target audience includes interventional cardiologists, radiologists, and hospitals specializing in cardiovascular care.
Features
- High-resolution intravascular imaging for detailed visualization of coronary artery lesions
- Advanced image processing algorithms for plaque characterization and quantification
- Integration with existing catheterization labs and imaging workflows
- User-friendly interface for easy image acquisition and interpretation
- Quantitative analysis of plaque burden, composition, and vulnerability
- 3D reconstruction of coronary arteries for comprehensive anatomical assessment